dr. reidy-lagunes on fda approval of telotristat epitrate for carcinoid syndrome
Published 7 years ago • 377 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
1:56
dr. anthony on treatment benefit with telotristat epitrate in patients with carcinoid syndrome
-
1:18
dr. lagunes on potential combinations in the treatment of patients with nets
-
1:27
dr. lowell anthony use of telotristat epitrate in patients with carcinoid syndrome
-
1:48
dr. reidy-lagunes on determining the site of unknown primary in metastatic nets
-
2:30
telotristat etiprate as a treatment option for carcinoid syndrome
-
9:15
the potential for combination therapy in neuroendocrine tumors
-
1:18
dr. lagunes on the importance of developing more personalized treatments in nets
-
2:12
emerging therapies for pnets
-
7:36
systemic treatment options and sequencing in pnets
-
3:26
challenges in sequencing and combination therapy in pnets
-
10:36
introduction: biology of pancreatic neuroendocrine tumors
-
46:40
lacnets - "telestar clinical trial results" dr. lapuerta
-
14:49
2018 la net conf 05 - managing symptoms - carcinoid syndrome & more: hendifar
-
6:10
peptide receptor radionuclide therapy in neuroendocrine tumors
-
44:30
lacnets - "prrt & netter-1 trial results" - dr. andrew hendifar
-
1:00:23
post-conference perspectives in gi cancers
-
2:57
corona doctor survives coronavirus, credits newly fda approved treatment
-
1:31
fda approves new treatment for allergies
-
0:54
what are the risks or side effects of medications used to manage arrhythmia? (evgueni fayn, md)